FDA Approves KALYDECO™ (ivacaftor) … to Treat the Underlying Cause of Cystic Fibrosis

FDA Approves KALYDECO™ (ivacaftor) ... to Treat the Underlying Cause of Cystic Fibrosis

Fred Van Goor, Ph.D., Head of Biology, CF Research Program, Vertex, discussing the path to KALYDECO discovery and development. http://www.businesswire.com/mu…
Video Rating: 5 / 5

Comments are closed.